1028. Use of Antisense Oligonucleotides To Restore Activity in Mutant p53
Publication
, Conference
Catron, DJ; Giangrande, PH; Sullenger, BA
Published in: Molecular Therapy
2006
Duke Scholars
Published In
Molecular Therapy
DOI
ISSN
1525-0016
Publication Date
2006
Volume
13
Start / End Page
S395 / S395
Publisher
Elsevier BV
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Catron, D. J., Giangrande, P. H., & Sullenger, B. A. (2006). 1028. Use of Antisense Oligonucleotides To Restore Activity in Mutant p53. In Molecular Therapy (Vol. 13, pp. S395–S395). Elsevier BV. https://doi.org/10.1016/j.ymthe.2006.08.1123
Catron, Daniel J., Paloma H. Giangrande, and Bruce A. Sullenger. “1028. Use of Antisense Oligonucleotides To Restore Activity in Mutant p53.” In Molecular Therapy, 13:S395–S395. Elsevier BV, 2006. https://doi.org/10.1016/j.ymthe.2006.08.1123.
Catron DJ, Giangrande PH, Sullenger BA. 1028. Use of Antisense Oligonucleotides To Restore Activity in Mutant p53. In: Molecular Therapy. Elsevier BV; 2006. p. S395–S395.
Catron, Daniel J., et al. “1028. Use of Antisense Oligonucleotides To Restore Activity in Mutant p53.” Molecular Therapy, vol. 13, Elsevier BV, 2006, pp. S395–S395. Crossref, doi:10.1016/j.ymthe.2006.08.1123.
Catron DJ, Giangrande PH, Sullenger BA. 1028. Use of Antisense Oligonucleotides To Restore Activity in Mutant p53. Molecular Therapy. Elsevier BV; 2006. p. S395–S395.
Published In
Molecular Therapy
DOI
ISSN
1525-0016
Publication Date
2006
Volume
13
Start / End Page
S395 / S395
Publisher
Elsevier BV
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences